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MLKL, a key component downstream of RIPK3, is
suggested to be a terminal executor of necroptosis.
Genetic studies have revealed that Ripk3 ablation
rescues embryonic lethality in Fadd- or Caspase-8-
deficient mice. Given that RIPK3 has also been
implicated in non-necroptotic pathways including
apoptosis and inflammatory signaling, it remains un-
clear whether the lethality in Fadd/ mice is indeed
caused by necropotosis. Here, we show that genetic
deletion of Mlkl rescues the developmental defect in
Fadd-deficient mice and that Fadd/Mlkl/ mice
are viable and fertile. Mlkl/Fadd/ mice display
significantly accelerated lymphoproliferative disease
characterized by lymphadenopathy and spleno-
megaly when compared to Ripk3/ Fadd/ mice.
Mlkl/Fadd/ bone-marrow-derived macrophages
and dendritic cells have impaired NLRP3 inflamma-
some activation associated with defects in ASC
speck formation and NF-kB-dependent NLRP3 tran-
scription. Our findings reveal that MLKL and FADD
play critical roles in preventing lymphoproliferative
disease and activating the NLRP3 inflammasome.
INTRODUCTION
Regulated cell death including apoptosis and necroptosis plays
essential roles in the development, homeostasis, and patholog-
ical processes of mammals. Apoptosis can be triggered through
the death receptors (DRs), including tumor necrosis factor recep-
tor-1 (TNFR1) and FAS (Nagata, 1997). Activated by their ligands,
DRs recruit the adaptor protein Fas-associated death domain
(FADD), which binds and activates caspase-8 to initiate
apoptosis (Boldin et al., 1996; Muzio et al., 1996; Zhang and Wi-
noto, 1996). In the absence of active caspase-8, receptor-inter-Cell Report
This is an open access article under the CC BY-Nacting protein kinase 1 (RIPK1) and RIPK3 interact with each
other, forming a microfilament-like complex that is known as ne-
crosome (Li et al., 2012; Orozco et al., 2014; Vercammen et al.,
1998). MLKL, the mixed lineage kinase domain-like protein, has
been identified as a key component downstream of RIPK3 (Sun
et al., 2012; Zhaoet al., 2012). Recent studies havedemonstrated
that MLKL is phosphorylated by RIPK3 and form oligomers that
translocate to cell membrane, leading to the disruption of mem-
brane integrity (Cai et al., 2014; Chen et al., 2014; Dondelinger
et al., 2014;Orozco et al., 2014; Suet al., 2014;Wanget al., 2014).
The in vivo mechanism of RIPK1-RIPK3 necrosome-mediated
necroptosis has been elucidated through intensive genetic
studies. Targeted deletion of Fadd or Caspase-8 in mice causes
embryonic lethality around embryonic day 11.5 (Varfolomeev
et al., 1998; Yeh et al., 1998), which is probably due to vascular,
cardiac, and hematopoietic defects (Kang et al., 2004, 2008; Sa-
kamaki et al., 2002). The death of Fadd/ or Casp8/ embryo
can be rescued by co-deletion of Ripk1; however, similar to
Ripk1/ mice, these mice die perinatally (Zhang et al., 2011;
Rickard et al., 2014; Dillon et al., 2014; Kaiser et al., 2014; Kelliher
et al., 1998). Deletion of Ripk3 in Fadd/ or Casp8/mice also
prevents the embryonic lethality (Dillon et al., 2012; Kaiser et al.,
2011; Oberst et al., 2011); by contrast, Ripk3/Fadd/ and
Ripk3/Casp8/ mice grow into fertile adults. Furthermore,
co-deletion of Ripk3 and either Fadd or Caspase-8 can rescue
Ripk1/ mice into adulthood (Rickard et al., 2014; Dillon et al.,
2014; Kaiser et al., 2014; Dowling et al., 2015). During necropto-
sis, the pseudokinase MLKL acts as a terminal executor down-
stream of necrosome formation. Thus, the strong evidence
regarding the early embryonic death of Fadd or Caspase-8-
deficient mice caused by RIPK3-dependent necroptosis could
come from investigating putative MLKL functions in the Fadd
or Caspase-8-deficient background.
Although the mice deficient in both Fadd and Ripk3 are
viable, they display a profound lymphoproliferative disease over
time with a large accumulation of B220+ CD3+ T lymphocytes.
Similar phenomena are observed in Ripk3/Casp8/ mice and
Ripk3D161N/D161NCasp8/ mice (Dillon et al., 2012; Kaiser et al.,s 16, 3247–3259, September 20, 2016 ª 2016 The Author(s). 3247
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
AC
E
D
B
(legend on next page)
3248 Cell Reports 16, 3247–3259, September 20, 2016
2011; Newton et al., 2014; Oberst et al., 2011). Meanwhile, this
disease also occurred in mice and humans containing mutations
in FAS or FASL (Wilson et al., 2009). It is notable that Caspase-
8/Ripk3/Ripk1/ mice that are backcrossed to C57BL/6
mice background show milder lymphoproliferative disease
compared to Caspase-8/Ripk3/ mice (Rickard et al., 2014;
Dillon et al., 2014; Dowling et al., 2015), whereas the TKO mice
generated without backcrossing display an opposite phenotype
(Kaiser et al., 2014). These results indicate that the extent of the
backcross of knockoutmicemay have to dowith the phenotypes.
Interestingly, genetic loss of both FASL and TRAIL in mice dis-
plays more severe disease than in FASL mutant mice (Sedger
et al., 2010), which indicates that FASmay be one of the death re-
ceptors involving in progressive lymphoproliferative disease.
Together, the precise contributions of cell death pathways in the
pathogenesis of lymphoproliferative disease remain unclear.
Another important process closely related to necrosis is in-
flammatory response. Damage-associated molecular patterns
(DAMPs) released from necrotic cells stimulate immune cells
through ligation of pattern recognition receptors (PRRs) to secret
pro-inflammatory cytokines such as interleukin-1b (IL-1b) and IL-
18, which subsequently activate host immune defenses against
various pathogens. The maturation of IL-1b and IL-18 is medi-
ated by cytosolic NOD-like receptors (NLRs) and HIN domain-
containing family member AIM2, which associate with other
proteins to form large multimeric complex that is known as the
inflammasome (Agostini et al., 2004; Davis et al., 2011; Schroder
and Tschopp, 2010). The NLRP3 inflammasome, the most
extensively studied one, consists of NLRP3, the apoptosis-
associated speck-like protein containing a CARD (ASC) and
pro-caspase-1. Processed by the NLRP3 inflammasome, active
caspase-1 subsequently promotes the maturation of the pro-in-
flammatory cytokines IL-1b and IL-18 (Fernandes-Alnemri et al.,
2007; Latz et al., 2013; Schroder et al., 2012).
In Caspase-8-deficient bone-marrow-derived dendritic cells
(BMDCs), the NLRP3 inflammasome can be activated by lipo-
polysaccharide (LPS) treatment alone in a RIPK3-dependent
manner, which is consistent with the results from cells deficient
in XIAP, cIAP1, and cIAP2. Similarly, treatment of bone-
marrow-derived macrophages (BMDMs) or BMDCs with Smac
mimetics leads to the NLRP3 inflammasome activation, which
requires RIPK3 (Kang et al., 2013; Silke et al., 2015; Vince
et al., 2012). These results indicate that cIAP or caspase-8 in-
hibits RIPK3 mediated the NLRP3 inflammasome activation.
Nevertheless, recent studies show that Fadd/Ripk3/ and
Caspase-8/Ripk3/ BMDMs are unable to activate the
NLRP3 inflammasome upon stimulation while activation in
Ripk3/ BMDMs is normal. This result suggests that caspase-
8 or FADD, instead of RIPK3, may play an important role in the
NLRP3 inflammasome activation (Gurung et al., 2014; Silke
et al., 2015). These seemingly contradictory results interest usFigure 1. Embryonic Lethality in Fadd Deficiency Mice Is Rescued by M
(A) Photographs of embryos of the indicated genotypes at E11.5.
(B) Photographs of 12-week-old mice of the indicated genotypes.
(C) Predicted and observed frequencies of mice born following Mlkl+/Fadd+/ in
(D) Plot of weight of littermate wild-type, Mlkl/, and Mlkl/Fadd/ mice.
(E) Immunoblot of RIPK1, RIPK3, MLKL, FADD, caspase-8, and b-actin of lymphin investigating the NLRP3 activation in MLKL and FADD dou-
ble-knockout background.
In this study, we demonstrate that Mlkl deletion rescued em-
bryonic lethality caused by Fadd deficiency. Mlkl/Fadd/
mice survived to adulthood but displayed severer lymphoproli-
ferative disease compared to the Ripk3/ Fadd/ mice.
Furthermore, we found that the NLRP3 inflammasome activation
was inhibited inMlkl/Fadd/BMDMs andBMDCswhen chal-
lenged with LPS or poly(I:C). Thus, our study revealed indispens-
able roles of MLKL in mediating embryonic lethality of Fadd-defi-
cient mice and suppressing progressive lymphoproliferative
disease, more importantly, the potential function of MLKL and
FADD in regulating inflammasome activation.
RESULTS
Embryonic Lethality Caused by Fadd Deficiency Is
Rescued by Mlkl Deletion
Ablation of Fadd in mice causes embryonic death in mice be-
tween E10.5 and E11.5, which is probably due to themassive ne-
crosis (Figure 1A). To evaluate the in vivo function ofMLKL in em-
bryonic development, we performed targeted disruption of Mlkl
by CRISPR/Cas9 gene mutation system and crossed the Mlkl
knockout alleles into Fadd knockout mice (Figures S1A and
S1B). As expected, Mlkl deletion rescued embryonic lethality
caused by Fadd deficiency. The resulting Mlkl/Fadd/ mice
were viable and fertile, and the newborns were weaned at ex-
pected frequencies (Figures 1B and 1C). Mlkl/Fadd/ mice
were almost indistinguishable from their Mlkl/ and wild-type
littermates in physical appearance and growth (Figures 1B and
1D). The immunoblot results showed undetectable expression
of MLKL and FADD in multiple organs of Mlkl/Fadd/ mice
(Figures 1E and S1D). Previous studies have reported that the
mice with specific deficiency of Fadd or Caspase-8 in epithelial
cells resulted in terminal ileitis or chronic intestinal inflammation,
which was prevented by the co-deletion of Ripk3 (Welz
et al., 2011). Besides, keratinocyte-specific Fadd deficiency
promoted RIPK3-dependent necroptosis and skin inflammation
in mice (Bonnet et al., 2011). Consistent with these results,
Mlkl/Fadd/ mice exhibited no sign of chronic inflammation
in skin or intestine when observed for over 5 months (Figures
1B and S1C), suggesting that RIPK3-MLKL-mediated necropto-
sis in epithelial cells is likely to participate in the pro-inflammatory
signaling pathways when caspase-8 or FADD is inhibited. In
conclusion, these results demonstrate that MLKL functionally
mediates the consequences of Fadd deficiency in vivo.
Mlkl/Fadd/ Mice Are Resistant to DR-Induced
Apoptosis and Necroptosis
Cell death mostly initiates through the ligation of DRs and
the signaling is relayed through a series of protein-proteinlkl Deletion
tercross. yPredicted embryonic lethal.
nodes, spleen, and thymus from mice of the indicated genotypes.
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Figure 2. Sensitivities to DR-Induced Apoptosis and Necroptosis Both In Vitro and In Vivo
(A) Wild-type and littermate Mlkl/Fadd/ MDFs were treated with mouse TNF-a (30 ng/ml), TNF-a+Smac mimetic (100 nM), TNF-a+Smac mimetic+zVAD
(20 mM), and TNF-a+ Smac mimetic+zVAD+Necrostatin1(30 mM), respectively.
(B) Thymuses from wild-type and littermate Mlkl/Fadd/ mice were milled and filtered into single cells. Thymocytes were treated with CHX (30 mg/ml), Fas
ligand (100 ng/ml)+CHX, Fas ligand+CHX+zVAD (20 mM), and Fas ligand+CHX+zVAD+ Necrostatin1 (30 mM), respectively.
(C) Bone marrow from wild-type and littermate Mlkl/Fadd/ mice were induced by M-CSF (50 ng/ml) for 1 week. BMDMs from indicated genotypes
were challenged with LPS (100 ng/ml), LPS+zVAD (20 mM), LPS+zVAD+Necrostatin1 (30 mM), Poly(I:C) (100 mg/ml), and Poly(I:C)+z VAD, Poly(I:C)+z
VAD+Necrostatin-1, respectively.
(A–C) Cell viability was determined using the CellTiter-Glo kit. The data are represented as the mean ± SD of triplicate wells. ***p < 0.001(Student’s t test).
Abbreviations are as follows: UT, untreated; T, TNF-a; S, Smac mimetic; Z, zVAD; N, necrostatin. F, Fas ligand; C, CHX; L, LPS; P, Poly(I:C).
(D) Kaplan-Meier survival plot of 8-week-old wild-type (n = 7) and Mlkl/Fadd/ (n = 7) mice injected intraperitoneally with 12.5 mg of anti-Fas Jo-2
antibody.
(E) Histology of liver sections from wild-type (left panel) and Mlkl/Fadd/ (right panel) mice 3 hr after Jo-2 antibody injection. Scale bars, 50 mm.interactions. To verify the disrupted functions of FADD and
MLKL in Mlkl/Fadd/ mice, we tested several types of cells
derived from wild-type (WT) and double-knockout (DKO) mice
for their sensitivities to DR-induced cell death. As expected,
WT mouse dermal fibroblasts (MDFs) had remarkable loss in
response to the combined treatment with TNF and the cIAP in-3250 Cell Reports 16, 3247–3259, September 20, 2016hibitor Smac mimetic. In the presence of caspase inhibitor
zVAD-fmk, almost half of the WT MDFs underwent necroptosis
which was inhibited by Necrostatin-1 (Figure 2A). Thymocytes
were killed by treatment with anti-Fas antibodies (Figure 2B).
In addition, BMDMs from WT mice were sensitive to LPS
or Poly(I:C)-induced necroptosis (Figure 2C). In contrast to
WT cells, cells from Mlkl/Fadd/ mice were completely
resistant to the extrinsic apoptosis and necroptosis triggered
by the stimuli described above (Figures 2A–2C). Furthermore,
Mlkl/Fadd/ mice were resistant to Fas-induced lethal hep-
atitis and survived for over 24 hr (Figure 2D) with normal liver
architecture (Figure 2E). Together, these results show that
FADD-dependent extrinsic apoptosis and MLKL-dependent
necroptosis are blocked in Mlkl/Fadd/ cells, indicating
that the functions of FADD and MLKL are eliminated in Mlkl/
Fadd/ mice.
Mlkl/Fadd/ Mice Display More Severe Progressive
Lymphoproliferative Disease Compared to
Ripk3/Fadd/ Mice
In all settings where Caspase-8 or Fadd deficiency has been
rescued by elimination of Ripk3 or the kinase activity of
RIPK3, resulting viable mice exhibit lymphoid hyperplasia
as they age (Dillon et al., 2012; Kaiser et al., 2011; Newton
et al., 2014; Oberst et al., 2011). Similar to Ripk3/Fadd/
or Ripk3/Caspase-8/ mice, Mlkl/Fadd/ mice displayed
swollen spleen and lymph nodes leading to a systematic lym-
phoproliferative disease over time but normal T cell population
in thymus (Figures 3A, S2A, and S2C). Histology staining indi-
cated excessive cell accumulation and abnormal structure in
spleen and lymph nodes from Mlkl/Fadd/ mice (Figures
3B and S2B). Cells accumulated in spleen and lymph nodes
were shown to be a population of B220+CD3+ T lymphocytes
(Figure 3C). Surprisingly, we observed that Mlkl/Fadd/
mice showed more severe lymphadenopathy and splenomegaly
than Ripk3/Fadd/ mice did (Figures 3A, 3B, S2A, and
S2B). Consistent with these phenotypes, a larger population
of B220+CD3+ T lymphocytes was accumulated in peripheral
lymphoid organs (especially in lymph nodes) of Mlkl/Fadd/
mice in comparison with contemporary Ripk3
/
Fadd/ mice
(Figure 3C). It seems that the remarkable distinction, comparing
to Ripk3/Fadd/ mice, should owe to the praecox lym-
phoaccumulation (started around 9 weeks old, data not shown)
and more rapid development of the disease in Mlkl/Fadd/
mice. Differences in organ sizes and B220+CD3+ T lymphocytes
percentage between two types of DKO mice became less
significant over time (Figures 3A, 3C, and S2A). Aging mice to
about 16 weeks old, we found enlarged parathymic lymph
nodes emerged beside the thymus (it appeared earlier in
Mlkl/Fadd/ mice than in Ripk3/Fadd/ mice), which
were confirmed to be accumulations of B220+CD3+ T lympho-
cytes similar to those shown in spleen and other lymph nodes
(Figures 3A, S2A, and S2C). The faster accumulation of
B220+CD3+ T lymphocytes we observed in Mlkl/Fadd/
mice indicated a divergence between these two genotypes in
cell proliferation. To test our hypothesis, we checked the cell
proliferation in peripheral lymph organs using Ki67 staining.
Compared with Ripk3/Fadd/ mice and WT controls, more
Ki67 positive cells were detected in peripheral lymph organs
of Mlkl/Fadd/ mice, indicating more active cell proliferation
(Figure S2D). Thus, our data implicate that hyperproliferation
of B220+CD3+ T lymphocytes contributes to more severe
lymphoproliferative disease in Mlkl/Fadd/ mice than in
Ripk3/Fadd/ mice.Mlkl/Fadd/ BMDMs Are Impaired in the NLRP3
Inflammasome Activation When Challenged with LPS or
Poly(I:C)
Inflammasomes are large intracellular multiprotein complexes
that play a central role in innate immunity. Recent studies have
provided some evidence that FADD, RIPK3, and MLKL may
be involved in regulating the NLRP3 inflammasome activation
(Gurung et al., 2014; Kang et al., 2013, 2015; Lawlor et al.,
2015; Silke et al., 2015; Vince et al., 2012). To investigate
the function of these proteins in the NLRP3 inflammasome
activation, we challenged Ripk3/Fadd/, Mlkl/Fadd/,
Ripk3/, and Mlkl/ BMDMs with LPS for priming and subse-
quently stimulated them with ATP to activate the canonical
NLRP3 inflammasome. In comparison with Ripk3/ andMlkl/
BMDMs, caspase-1 processing was significantly reduced in
Ripk3/Fadd/ and Mlkl/Fadd/ BMDMs (Figure 4A).
Consistently, IL-1b secretion was significantly decreased in
Ripk3/Fadd/ and Mlkl/Fadd/ BMDMs (Figure 4B).
These BMDMs were also primed with poly(I:C) and treated
with ATP for the inflammasome activation. Similar to the afore-
mentioned results, Mlkl/Fadd/ BMDMs had little response
to the treatment while the WT BMDMs had normal inflamma-
some activation (Figures 4C and 4D). Furthermore, the
similar set of experiments was also performed in BMDCs.
Mlkl/Fadd/BMDCswere defective in NLRP3 inflammasome
activation as well (Figures S4B and S4C). Previous studies have
revealed that FADD and caspase-8 were apical mediators of ca-
nonical and noncanonical NLRP3 inflammasome activation
(Kang et al., 2013; Silke et al., 2015; Vince et al., 2012; Gurung
et al., 2014). To investigate the cause of the defect in DKO
BMDMs, we examined the NLRP3 inflammasome activation in
BMDMs derived from LysM-cre-mediated cell-specific Fadd
deletion mice, and the deletion efficiency of FADD was tested
by immunoblot (Figure S4A). The results showed that LPS or
poly(I:C) primed BMDMs with low FADD expression had normal
caspase-1 processing and IL-1b secretion upon stimulation as
WT control (Figures 4E and 4F).
In conclusion, in contrast to the Ripk3/, Mlkl/and FADD
insufficient BMDMs, Ripk3/Fadd/ and Mlkl/Fadd/
BMDMs or BMDCs have impaired canonical NLRP3 inflamma-
some activation when challenged with LPS or Poly(I:C). Our
data suggest that MLKL is likely to function together with
FADD to co-regulate the canonical NLRP3 inflammasome
activation engaged through TLR3 or TLR4.
NLRP3 Inflammasome Activation Failure in
Mlkl/Fadd/ BMDMs Is Due to Defects of ASC Speck
Formation and NF-kB-Dependent NLRP3 Transcription
Formation of NLRP3 inflammasome requires the pyrin domain
(PYD) of NLRP3 to recruit the adaptor protein ASC through
PYD-PYD interaction. This interaction further facilitates the
recruitment of pro-caspase-1 to assemble the inflammasome
complex which is necessary for caspase-1 activation (Fer-
nandes-Alnemri et al., 2007; Sutterwala et al., 2014).
To investigate whether the impaired inflammasome activation
in Mlkl/Fadd/or Ripk3/Fadd/ BMDMs was due to a
defect in the complex formation, we analyzed the ASC polymer-
ization after LPS stimulation inMlkl/Fadd/,Ripk3/Fadd/Cell Reports 16, 3247–3259, September 20, 2016 3251
Figure 3. Mlkl/Fadd/ Mice Display More Severe Systemic Lymphoproliferative Disease Than Ripk3/Fadd/ Mice
(A) Lymph nodes, spleens, and thymus removed from 12- and 16-week-old mice of indicated genotypes.
(B) H&E-stained sections of fixed spleen from mice of indicated genotypes. Scale bars, 50 mm
(C) Percentage of B220+CD3+ cells from spleen and lymph nodes in 12- mice or 16-week-old mice of the indicated genotypes.
(D) Percentage of CD3+ cells in CD4CD8B220+ populations from lymph nodes of mice with indicated genotypes and ages. Error bars, SD for three wild-type,
three Ripk3/Fadd/ and three Mlkl/Fadd/ mice.
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Figure 4. Activation of Canonical NLRP3 Inflammasome in BMDMs
(A and C)Wild-type,Ripk3/,Mlkl/,Ripk3/Fadd/, andMlkl/Fadd/BMDMswere primedwith (A) 20 ng/ml LPS or (C) 100 mg/ml Poly(I:C) for 5 hr prior to
30-min treatment of 5 mM ATP. Supernatants were analyzed by immunoblot for caspase-1 activation.
(B and D) Wild-type, Ripk3/,Mlkl/, Ripk3/Fadd/, andMlkl/Fadd/ BMDMs were stimulated with (B) 20 ng/ml LPS or (D) 100 mg/ml Poly(I:C) for 12 hr
prior to 15-min treatment of 5 mM ATP. Supernatants were analyzed by ELISA for IL-1b secretion.
(E) Wild-type and FADD insufficient BMDMs were primed with 20 ng/ml LPS or (C) 100 mg/ml Poly(I:C) for 5 hr prior to 30-min treatment of 5 mM ATP. Super-
natants were analyzed by immunoblot for caspase-1 activation and (F) were analyzed by ELISA for IL-1b secretion. ***p < 0.001 (Student’s t test). n.s., not
significant.BMDMs, and controls. As expected, in contrast to controls,
Mlkl/Fadd/ and Ripk3/Fadd/ BMDMs had significantly
reduced ASC polymerization in both the pellet and the superna-
tant of cell lysates (Figure 5A). The same defects were shown
in Mlkl/Fadd/ and Ripk3/Fadd/ BMDCs (Figure S4D).
In line with the results above, significantly fewer ASC specks
formed in Mlkl/Fadd/ BMDMs than in WT BMDMs (Figures5B and 5C), suggesting that MLKL and FADD may mediate the
NLRP3 inflammasome activation through regulating ASC speck
formation.
As the key component of the inflammasome complex, NLRP3
can be upregulated by the priming signal. Thus, we examined
both NLRP3 protein level and mRNA level by immunoblot and
qRT-PCR, respectively. InMlkl/Fadd/ and Ripk3/Fadd/Cell Reports 16, 3247–3259, September 20, 2016 3253
Figure 5. ASC Polymerization in BMDMs upon LPS Stimulation
(A) Wild-type, Ripk3/,Mlkl/, Ripk3/Fadd/, andMlkl/Fadd/ BMDMs or for 5 hr prior to 30-min treatment of 5 mM ATP. Supernatants and cell pellets
were analyzed by immunoblot for ASC polymerization. Cell lysates were analyzed by immunoblot for the expression of ASC and NLRP3.
(B) Immunofluorescence microscopy of LPS-primed wild-type Mlkl/Fadd/ BMDMs without or with 5 mM ATP treatment, top (untreated), middle (LPS
primed), and bottom (ATP stimulation after LPS priming). Cells were fixed and immunostained for ASC (green) and NLRP3 (red). DAPI (blue) was used for nuclear
staining. Scale bars, 5 mm.
(C) Quantification of results from Figure 4B. Total cells and cells with an ASC polymer (speck) were counted, and the percentages of cells with ASC polymer were
calculated. The data are represented as the mean ± SD of five microscopic fields per group.
3254 Cell Reports 16, 3247–3259, September 20, 2016
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Figure 6. NF-kB Activation in BMDMs upon LPS Stimulation
(A–C) Wild-type, Ripk3/Fadd/, andMlkl/Fadd/ BMDMs were treated with 20 ng/ml LPS for 6 hr, and mRNA levels of NLRP3 (A), IL-1b (B), and ASC (C)
were determined by qPCR.
(D)Wild-type andMlkl/Fadd/BMDMswere treated with 100 ng/ml LPS for 15, 30, 60, and 90min, respectively. The expression of indicated the proteins were
detected by western blot.
(E and F) Wild-type, Ripk3/,Mlkl/, Ripk3/Fadd/, andMlkl/Fadd/ BMDMs were treated with 20 ng/ml LPS for 12 hr. Supernatants were collected for
the detections of TNF-a and IL-6 by ELISA.BMDMs treated with LPS, NLRP3 can hardly respond to
the priming signal compared with WT control while ASC had
normal transcription and expression levels in all BMDMs
(Figures 5A, 6A, and 6C). Besides, pro-IL1b, the substrate
of the activated inflammasome, was unable to be upregu-lated in Mlkl/Fadd/ and Ripk3/Fadd/ BMDMs either
(Figure 6B).
Given thatNLRP3 and pro-IL-1bare transcriptionally regulated
by NF-kB, we therefore examined NF-kB signals following
LPS stimulation in Mlkl/Fadd/ and wild-type BMDMs byCell Reports 16, 3247–3259, September 20, 2016 3255
Figure 7. Decreasing Cytokine Secretion in
Mlkl/Fadd/ Mice
(A–C) Wild-type and Mlkl/Fadd/ mice were
challenged with LPS (i.p., 54 mg/kg), and the pro-
ductions of serum IL-1b (A), TNF-a (B), and IL-6 (C)
were detected by ELISA 12 hr later. Each dot
represents one mouse.immunoblots (Bauernfeind et al., 2009; Schroder et al., 2012;
Sutterwala et al., 2014). We found that NF-kB activation was
significantly decreased associated with less phosphorylation
and degradation of IkB in both Mlkl/Fadd/ and Ripk3/
Fadd/ BMDMs than in WT BMDMs (Figure 6D). Furthermore,
we examined the secretion levels of TNF-a and IL-6, which are
the target genes of NF-kB. It was shown that Mlkl/Fadd/
BMDMs had notable reduction of TNF-a and IL-6 levels in com-
parison to WT controls (Figures 6E and 6F).
In summary, our findings suggest that the NLRP3 inflamma-
some formation is insensitive to LPS/ATP stimulation in Mlkl/
Fadd/ and Ripk3/Fadd/ BMDMs. This is likely due to the
defects in NF-kB-dependent Nlrp3 and pro-IL-1b transcriptions.
Consequently, the lack of NLRP3 and pro-IL-1b expression ren-
ders the Mlkl/Fadd/ and Ripk3/Fadd/ BMDMs inca-
pable of forming ASC speck and recruiting other components
to assemble the NLRP3 inflammasome complex, which results
in the failure of caspase-1 processing and mature IL-1b
secretion.
DISCUSSION
The findings of our study provide genetic evidence that MLKL
mediates the embryonic lethality of Fadd deficiency in vivo.
Combined with previous studies (Dillon et al., 2012; Kaiser
et al., 2011; Oberst et al., 2011; Varfolomeev et al., 1998; Yeh
et al., 1998), we speculate that, during the embryonic develop-
ment, RIPK3-MLKL-mediated necroptotic signaling is tightly
regulated by the caspase-8-FADD-cFLIP complex although
the function of MLKL in the condition of Caspase-8 genetic
ablation remains to be identified. Several studies have inti-
mated that Fadd or Caspase-8 deficiency induced RIPK3-
dependent pathway may target the yolk sac vasculature and3256 Cell Reports 16, 3247–3259, September 20, 2016hematopoietic cells during embryogen-
esis. However, direct evidence showing
that embryonic lethality of Fadd-deficient
mice is caused by RIPK3-MLKL-medi-
ating necroptosis must still be obtained.
Considering that the CRISPR/Cas9
system could introduce off-target effects
in the Mlkl knockout mice, we confirmed
the phenotypes using another Mlkl
knockout mouse line that was generated
by an independent single guide (sg)RNA
(Figures S3A and S3B). The two indepen-
dent lines of Mlkl knockout mice were
individually crossed into the same line
of Fadd-deficient mice, and the two line-
ages displayed equivalent properties,excluding the possibility that off-target effects contributed to
the phenotypes of Mlkl/Fadd/ mice (Figure S3C).
Previous studies have demonstrated that FASL-FAS signal-
ing kills unwanted cells through FADD/caspase-8-mediated
apoptosis during the development of lymphocytes. Conditional
deletion of Fadd or Caspase-8 in T cell results in proliferation
defects in response to activation signals (Zhang et al., 1998;
Kabra et al., 2001; Salmena et al., 2003; Ch’en et al., 2008), while
combined deletion of either Ripk3 or Mlkl and Fadd in an
intact germline leads to accumulation of abnormal CD3+B220+
T cells. Given that MLKL works downstream of RIPK3, we
hypothesize that the lack of MLKL may block other possible un-
defined cell signaling pathways independent of RIPK3, resulting
in the praecox accumulation of CD3+B220+ T cells in spleen and
lymph nodes in Mlkl/Fadd/ mice. Another possibility is that
more cell proliferation occurring inMlkl/Fadd/mice leads to
severer lymphoproliferative disease. However, the precise
mechanisms behind the interesting phenotypes remain to be
explored.
A high dose of LPS results in endotoxemia in mice and
subsequently leads to the massive systemic release of pro-
inflammatory cytokines. When we challenged Mlkl/Fadd/
mice with LPS to assess the capacity of initiating innate immu-
nity, we observed a dramatic reduction of cytokine release in
Mlkl/Fadd/ mice (Figures 7A–7C). We speculate that the
reduced cytokine secretion was due to impaired activation
of the NLRP3 inflammasome and NF-kB signaling as shown
in the previous investigations in Ripk3/Fadd/ mice and
Ripk3/Casp8/ mice (Gurung et al., 2014; Kang et al.,
2013). The defects in both DKO mice raise an important issue
about how the NF-kB signaling in DKO BMDMs is regulated.
Although conditional deletion of Fadd in BMDMs have negli-
gible effects on the activation of inflammasome upon the
stimulation of LPS or Poly(I:C) as Mlkl/ or Rip3/ BMDMs
(Figures 4E and 4F), it remains likely that FADD alone deter-
mines the NLRP3 inflammasome activation due to its incom-
plete deletion (Figure S4A). Thus, we hypothesized that
RIPK3/MLKL and FADD/caspase-8 may co-regulate a target
or targets that mediate NF-kB signaling upon LPS or Poly(I:C)
stimulation. Nevertheless, the functions of these proteins in
regulating the targets need to be clarified by sophisticated
biochemical studies, and their functions in activating non-
canonical NLRP3 inflammasome and other types of inflamma-
somes should be further investigated.
The findings that FADD restricted MLKL-dependent pathway
during embryonic development and in maintaining the homeo-
stasis of T cell suggest the importance of the interplay between
FADD-dependent apoptosis and MLKL-dependent necroptosis.
More importantly, the key components of the two cell death
pathways may function as regulators in other situations as we
have observed in stimulating BMDMs or BMDCs. In this light, it
is noteworthy that our findings here point out MLKL and FADD,
which are multifunctional in regulating cell death and innate
immune response, have broad implications for the related inves-
tigations as well as approaches to therapies of cancer and im-
mune disorders.
EXPERIMENTAL PROCEDURES
Reagents
LPS, ATP, and PolyI:Cwere obtained fromSigma. TNF-a and z-VADwere from
R&D Systems and Calbiochem, respectively. Necrostatin-1 was purchased
from Enzo Life Sciences. The following antibodies were used for western blot-
ting and immunofluorescence experiments: RIPK1 (BD Biosciences), RIPK3
(Prosci), IkBa and p- IkBa (Cell Signaling Technology), ASC (Santa Cruz
Biotechnology), IL-1b (Santa Cruz), mouse caspase-1 (AdipoGen), NLRP3
(R&D). MLKL antibody was a gift from Dr. Jiahuai Han (Xiamen University).
FADD antibody was from Dr. Jianke Zhang (Thomas Jefferson University).
Mouse TNF-a, IL-6, and IL-1b ELISA Kits were from MultiSciences. Cell
viability was determined by measuring ATP levels using the Cell Titer-Glo kit
(Promega).
Mice
Mice were housed in a specific pathogen-free (SPF) facility. Ripk3 knockout
mice were provided by Dr. Xiaodong Wang (NIBS, Beijing, China), and
Fadd/Tg mice were provided by Dr. Jianke Zhang (Thomas Jefferson Uni-
versity). Mlkl knockout mice were generated by CRISPR-Cas9 mutation sys-
tem (Bioray Laboratories). A 301-bp deletion in the Mlkl gene was introduced
in theMlkl locus, and genotyping results of mice are presented in Figures S1A
and S1B. Additional information is provided upon request. Animal experiments
were conducted in accordance with the guidelines of the Institutional Animal
Care and Use Committee of the Institute for Nutritional Sciences, Shanghai
Institutes for Biological Sciences, Chinese Academy of Sciences (CAS).
Cell Survival Assay
Cell survival was determined using the CellTiter-Glo Luminescent Cell Viability
Assay kit, and the luminescence was recorded with a microplate luminometer
(Thermo Scientific).
Isolation of Mouse BMDMs and Inflammasome Activation
Bone marrow cells were collected from mouse femurs and tibias and were
cultured for 7 days in RPMI medium containing 10% fetal bovine serum
(FBS), penicillin, streptomycin, and 50 ng/ml M-CSF. Medium was changed
every 2 days. BMDMs were induced to differentiate in vitro from isolated
bone marrow cells. For inflammasome assays, BMDMs were pretreated with
LPS or Poly(I:C) for 5 hr before stimulated with ATP (5 mM) for 30 min. The me-dia supernatant and cell lysates were collected for precipitation and immuno-
blot analysis.
ASC Oligomerization Detection
ASC pyroptosomeswere detected as previously reported (Juliana et al., 2010).
Macrophages were seeded in 6-well plates (23 106 cells per well) and treated
with different stimuli. The cells were pelleted by centrifugation and resus-
pended in 0.5 ml of ice-cold buffer containing 20 mM HEPES-KOH (pH 7.5),
150 mM KCl, 1% Nonidet P-40, 0.1 mM PMSF, and a protease inhibitor
mixture. Cell lysates were centrifuged at 5,000 3 g for 10 min at 4C, and pel-
lets were washed twice with PBS before being resuspended in 500 ml of PBS.
The pellets were crosslinked with fresh DSS (4 mM) for 30 min and pelleted by
centrifugation at 5,0003 g for 10min. Crosslinked pellets were resuspended in
30 ml of SDS sample buffer and subjected to western blot with the anti-mouse
ASC antibodies.
Statistical Analysis
Data presented in this article are representative results of at least three inde-
pendent experiments. The in vitro results were presented as the mean ± SD
of triplicate wells. The statistical significance of data was evaluated by Stu-
dent’s t test in which p < 0.01 was considered significant and p < 0.001 was
highly significant. The statistical calculations were performed with GraphPad
Prism software.
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